Author, Neurologist, Medical Director
Dr. Ilene Ruhoy is a board-certified neurologist and an environmental toxicologist who specializes in chronic and complex illness. She graduated from the University of Pittsburgh School of Medicine and completed her residency in neurology at the University of Washington where she also did additional fellowship training in neuromuscular disorders. She earned a PhD in Environmental Toxicology at the University of Nevada, working directly with the Environmental Protection Agency (EPA) on her dissertation topic of 'Pharmaceutical Residues in the Water.' Dr. Ruhoy also completed a fellowship in Integrative Medicine with Dr. Andrew Weil at the University of Arizona.
Dr. Ruhoy's interests include connective tissues disorders such as EDS, autoimmune neurological disorders, neuromuscular disorders, intracranial vascular and pressure disorders, infection associated neurological conditions such as Long Covid, MECFS, and PANS/PANDAS, traumatic and inflammatory brain injury, mitochondrial disease, neurodegeneration, and exposure illness.
Dr. Ruhoy has a private concierge practice in Seattle, WA, and has become a well sought after speaker on the role of connective tissue in neurological disease. She is currently a co-editor of the special issue of Neurology and Connective Tissue for Frontiers in Neurology and is working on a chapter entitled Ehlers Danlos Syndrome for a textbook on Vascular Compression Syndromes to be published by Springer Nature. Dr. Ruhoy has also been a co-editor of Integrative Neurology published by Oxford Press and a co-editor of Preventive Neurology, of the Seminars in Neurology series. She is also working on an invited chapter on EDS and hypermobility for a Springer text on Vascular Compression Syndromes. She is the Chair of the Neurology Working Committee for the EDS Society and isa member of the Neurology Working Group for the national apheresis organization, AFSA. She has been part of many chronic illness committees and serves on the boards of several organizations that focus on patients with EDS and chronic neurological disease.